DIARY M1 TABLETS
Offers Longer Action in Diabetes
Composition:
Each uncoated Tablets Contains:
Metformin hydrochloride IP 500 mg
(As sustained release form)
Glimepiride IP 1 mg
Higher Bio-Availability: Matches International Standards
Longer Duration of Action
Better Tolerability
Choice of Two Strengths Ensures
Dosage Flexibility
Effective Glycemic Control
Reduced Risk of Hypoglycemia
Indication of glimepiride metformin combination:
-
Non Insulin Dependent Diabetes
-
Maturity Onset (Non Insulin Dependent) Obese Diabetics In Whom Diet Alone Has Failed
Contra-indications of glimepiride metformin combination:
-
Renal Failure
-
Cardiovascular Collapse
-
Diabetic Ketoacidosis
-
Severe Hepatic In Sufficiency
-
Hypersensitivity
-
Pregnancy
-
Lactation
Drug interaction of glimepiride metformin combination:
-
Insulin
-
Other Oral Anti Diabetics
Side effects of glimepiride metformin combination:
-
Temporary Visual Impairment
-
Abdominal Pain
-
GI Disturbances
-
Tolerance
-
Hypoglycemia
-
Lactic Acidosis
Packaging of glimepiride metformin combination:
1* 10 Bilayer Tablets Blister Pack (10*10 Tab Carton)
available in Uncoated bilayered tablet
For Use of registered medical practitioner or a hospital only
